To further elucidate the signaling underlying the β3-AR/PD-L1 cross-talk in our tumor model of NB, we first assayed in vitro the expression of PD-L1 on N2A tumor cells following TNF-α and IFN-γ treatment. This evidence concerns the gene ADRB3 and neuroblastoma.